- Zacks•4 hours ago
Seattle Genetics (SGEN) reported a loss of 23 cents per share, narrower than both the Zacks Consensus Estimate of a loss of 33 cents.
- Capital Cube•yesterday
Click here to see latest analysisTakeda Pharmaceutical Co., Ltd. reports financial results for the year ended March 31, 2016.We analyze the earnings along side the following peers of Takeda Pharmaceutical Co., Ltd. – Johnson & Johnson and Novartis AG Sponsored ADR (JNJ-US and NVS-US) that have also reported for this period.HighlightsGross margins widened from 63.81% […] (Read more...) The post Takeda Pharmaceutical Co., Ltd. :TKPYY-US: Earnings Analysis: 2016 By the Numbers : July 26, 2016 appeared first on CapitalCube.
Takeda Pharmaceutical Co Ltd will accept initial bids for its 70 percent stake in a chemicals company through Aug. 16, with potential suitors including CVC Capital Partners Ltd and Carlyle Group Ltd, sources told Reuters. Takeda, Japan's largest drugmaker by market value, aims to sell its holding in Wako Pure Chemicals Industries Ltd to streamline operations, four people familiar with the plan said, declining to be identified as the matter was private. The drugmaker is likely to receive an aggressive bid from Fujifilm Holdings Corp, which is seeking to expand its medical business and already owns 9.5 percent of Wako Pure, the people said.
Takeda Pharmaceutical Company LimitedOther OTC
|52wk Range||20.32 - 26.52|
|Day's Range||21.43 - 21.80|
|Avg Vol (3m)||66,536|
As of 12:31 PM EDT. Other OTC Delayed Price. Market open.